[PMC free content] [PubMed] [Google Scholar] 3. antigens ranged from 15.0% to 76.2%. Antibody frequencies had been reduced considerably for 54 of 62 specificities when the individual possessed an antigen cross-reactive using the donor mismatch, however the magnitude of the result was adjustable and ranged from 8% to 83%. Furthermore, there is directionality in the protecting effect of cross-reactive group coordinating. Overall imply donor-specific antibody frequencies were comparable for men and women except for a significantly higher rate of recurrence of antibodies to HLA-DR among males (56.6% vs. 47.8%, test appropriate for the data set. Supplementary Material SUPPLEMENTARY MATERIAL:Click here to view.(53K, doc) Footnotes The authors declare no conflicts of interest. D.P.L. and A.A.Z. participated in study design, writing of the article, performance of the research, and analysis of data. M.S.L. participated in study design and writing of the article. Supplemental digital content material (SDC) is available for this short article. Direct Web address citations appear in the imprinted text, and links to the digital documents are provided in the HTML text of this article on the journals Internet site (www.transplantjournal.com). Recommendations 1. Akalin E, Pasqual M. Sensitization after kidney transplantation. Clin J Am Soc Nephrol 2006; 1: 443. [PubMed] [Google Scholar] 2. Valenzuela NM, PHCCC McNamara JT, Reed EF. Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. Curr Opin Organ Transplant 2014; 19: 33. [PMC free article] [PubMed] [Google Scholar] 3. Yamanaga S, Watarai Y, Yamamoto T, et al.Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and bad CDC crossmatches. Hum Immunol 2013; 74: 1111. [PubMed] [Google Scholar] 4. Lachmann N, Terasaki PI, Budde K, et al.Anti-human leukocyte antigen and donor-specific antibodies recognized by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009; 87: 1505. [PubMed] [Google Scholar] 5. Iyer HS, Jackson AM, Zachary AA, et al.Transplanting the highly sensitized patient: trials and tribulations. Curr Opin Nephrol Hypertens 2013; 22: 681. [PubMed] [Google Scholar] 6. Gralla J, Tong S, Wiseman AC. The effect of human being leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after 1st graft failure in pediatric renal transplant recipients. Transplantation 2013; 95: 1218. [PubMed] [Google Scholar] 7. Zachary AA, Hart JM, Lucas DP, et al.The cost of mismatching. In: Cecka JM, Terasaki PI, eds. Rabbit Polyclonal to SEPT1 Clinical Transplants 2007. Los Angeles: Terasaki Basis; 2008: 261. [Google Scholar] 8. Dankers MKA, Witvliet MD, Roelen DL, et al.The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human being leukocyte antigens. Transplantation 2004; 77: 1236. [PubMed] [Google Scholar] 9. Duquesnoy RJ. A structurally centered approach to determine HLA compatibility in the humoral immune level. Hum Immunol 2006; 67: 847. [PMC free article] [PubMed] [Google Scholar] 10. Akkoc N, Scornik JC. HLA epitope coordinating. Contribution of matched residues to epitopes identified by alloantibodies. Transplantation 1991; 52: 903. [PubMed] [Google Scholar] 11. Mariuzza RA, Phillips SE, Poljak RJ. The structural basis of antigen-antibody acknowledgement. Annu Rev Biophys Biophys Chem 1987; PHCCC 16: 139. [PubMed] [Google Scholar] 12. Kosmoliaptsis V, Dafforn TR, Chaudhry AN, et al.High-resolution, three-dimensional modeling of human being leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. Hum Immunol 2011; 72: 1049. [PubMed] [Google Scholar] 13. Duquesnoy RJ, Claas FHJ. 14th International HLA and Immunogenetics Workshop: statement within the structural basis of HLA compatibility. Cells Antigens 2007; 69s1: 180. [PubMed] [Google Scholar] 14. El-Awar N, Terasaki PI, Cai J, et al.Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens. In: PHCCC Cecka JM, Terasaki PI, eds..